SMTL ID : 8qyu.1 (1 other biounit)

Beta-cardiac myosin S1 fragment in the pre-powerstroke state complexed to Omecamtiv mecarbil

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.96 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)

ADP.1: 18 residues within 4Å: Chain A: I.114, N.126, P.127, Y.128, K.129, Y.134, E.179, S.180, G.181, A.182, G.183, K.184, T.185, V.186, N.238, N.240 Ligands: VO4.2, MG.3 18 PLIP interactions: 18 interactions with chain A Hydrogen bonds: A:N.126, A:Y.134, A:G.181, A:A.182, A:G.183, A:K.184, A:T.185, A:V.186, A:N.238 Water bridges: A:T.185, A:N.187, A:N.187, A:N.187, A:N.240, A:N.240, A:S.242, A:D.461 Salt bridges: A:K.184

1 x VO4: VANADATE ION(Non-covalent)

VO4.2: 10 residues within 4Å: Chain A: S.180, G.181, K.184, N.238, S.241, S.242, A.463, G.464 Ligands: ADP.1, MG.3 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:G.181, A:K.184, A:N.238, A:S.241, A:S.242, A:S.242, A:G.464 Water bridges: A:R.243, A:G.464

1 x MG: MAGNESIUM ION(Non-covalent)

MG.3: 4 residues within 4Å: Chain A: T.185, S.242 Ligands: ADP.1, VO4.2 4 PLIP interactions: 2 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:T.185, A:S.242, H2O.1, H2O.2

1 x FMT: FORMIC ACID(Non-functional Binders)

FMT.4: 5 residues within 4Å: Chain A: E.264, T.265, N.437, V.440, T.441 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.265, A:T.265

3 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.5: 8 residues within 4Å: Chain A: F.494, Q.498, F.510, I.511, D.512, F.513, G.514, M.515 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:F.513, A:G.514, A:M.515 Salt bridges: A:D.512 DMS.6: 7 residues within 4Å: Chain A: E.179, S.180, R.237, F.465, E.466, I.467, I.674 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:I.467 Salt bridges: A:E.179 DMS.7: 8 residues within 4Å: Chain A: L.120, H.492, M.493, E.497, C.705, P.710, R.712 Ligands: 2OW.8 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:E.497

1 x 2OW: methyl 4-(2-fluoro-3-{[(6-methylpyridin-3-yl)carbamoyl]amino}benzyl)piperazine-1-carboxylate(Non-covalent)

2OW.8: 15 residues within 4Å: Chain A: K.146, R.147, Y.164, T.167, D.168, H.492, H.666, P.710, N.711, R.712, R.721, Y.722, L.770, E.774 Ligands: DMS.7 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:T.167, A:L.770 Hydrogen bonds: A:D.168, A:D.168, A:N.711, A:R.712 Water bridges: A:R.712 Salt bridges: A:E.774 pi-Stacking: A:H.666

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Auguin, D. et al., Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contraction. Biorxiv (2023)

Release Date

2023-12-13

Peptides

Myosin-7: A
Myosin light chain 3: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
H

Myosin-7

Myosin light chain 3

Related Entries With Identical Sequence